BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang C, Vegna S, Jin H, Benedict B, Lieftink C, Ramirez C, de Oliveira RL, Morris B, Gadiot J, Wang W, du Chatinier A, Wang L, Gao D, Evers B, Jin G, Xue Z, Schepers A, Jochems F, Sanchez AM, Mainardi S, Te Riele H, Beijersbergen RL, Qin W, Akkari L, Bernards R. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature 2019;574:268-72. [PMID: 31578521 DOI: 10.1038/s41586-019-1607-3] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 27.3] [Reference Citation Analysis]
Number Citing Articles
1 Ferrín G, Guerrero M, Amado V, Rodríguez-Perálvarez M, De la Mata M. Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E1266. [PMID: 32070029 DOI: 10.3390/ijms21041266] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
2 Dolgin E. Send in the senolytics. Nat Biotechnol 2020;38:1371-7. [DOI: 10.1038/s41587-020-00750-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
3 Lorenzo-Martín LF, Menacho-Márquez M, Bustelo XR. Drug Vulnerabilities and Disease Prognosis Linked to the Stem Cell-Like Gene Expression Program Triggered by the RHO GTPase Activator VAV2 in Hyperplastic Keratinocytes and Head and Neck Cancer. Cancers (Basel) 2020;12:E2498. [PMID: 32899210 DOI: 10.3390/cancers12092498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Suski JM, Braun M, Strmiska V, Sicinski P. Targeting cell-cycle machinery in cancer. Cancer Cell 2021;39:759-78. [PMID: 33891890 DOI: 10.1016/j.ccell.2021.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Jin H, Shi Y, Lv Y, Yuan S, Ramirez CFA, Lieftink C, Wang L, Wang S, Wang C, Dias MH, Jochems F, Yang Y, Bosma A, Hijmans EM, de Groot MHP, Vegna S, Cui D, Zhou Y, Ling J, Wang H, Guo Y, Zheng X, Isima N, Wu H, Sun C, Beijersbergen RL, Akkari L, Zhou W, Zhai B, Qin W, Bernards R. EGFR activation limits the response of liver cancer to lenvatinib. Nature 2021;595:730-4. [PMID: 34290403 DOI: 10.1038/s41586-021-03741-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang Y, Kui L, Wang G. Combination therapy for HCC: from CRISPR screening to the design of clinical therapies. Signal Transduct Target Ther 2021;6:359. [PMID: 34608130 DOI: 10.1038/s41392-021-00775-1] [Reference Citation Analysis]
7 Santos-de-Frutos K, Djouder N. When dormancy fuels tumour relapse. Commun Biol 2021;4:747. [PMID: 34135460 DOI: 10.1038/s42003-021-02257-0] [Reference Citation Analysis]
8 Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Genes Dev 2020;34:1565-76. [PMID: 33262144 DOI: 10.1101/gad.343129.120] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 24.0] [Reference Citation Analysis]
9 Gao Y, Hu Y, Liu Q, Li X, Li X, Kim CY, James TD, Li J, Chen X, Guo Y. Two-Dimensional Design Strategy to Construct Smart Fluorescent Probes for the Precise Tracking of Senescence. Angew Chem Int Ed Engl 2021;60:10756-65. [PMID: 33624914 DOI: 10.1002/anie.202101278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Carpenter V, Saleh T, Min Lee S, Murray G, Reed J, Souers A, Faber AC, Harada H, Gewirtz DA. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy. Biochem Pharmacol 2021;193:114765. [PMID: 34536356 DOI: 10.1016/j.bcp.2021.114765] [Reference Citation Analysis]
11 Yang C, Chen J, Li Y, Huang X, Liu Z, Wang J, Jiang H, Qin W, Lv Y, Wang H, Wang C. Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screen. Brief Bioinform 2021;22:bbaa295. [PMID: 33167027 DOI: 10.1093/bib/bbaa295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
12 Tian J, Shi D, Zhang Y, Li X, Li X, Teng H, James TD, Li J, Guo Y. Stress response decay with aging visualized using a dual-channel logic-based fluorescent probe. Chem Sci 2021;12:13483-91. [PMID: 34777768 DOI: 10.1039/d1sc04162b] [Reference Citation Analysis]
13 Zhang H, Li J, Chen Y, Wu J, Wang K, Chen L, Wang Y, Jiang X, Liu Y, Wu Y, Jin D, Bu W. Magneto-Electrically Enhanced Intracellular Catalysis of FePt-FeC Heterostructures for Chemodynamic Therapy. Adv Mater 2021;33:e2100472. [PMID: 33759262 DOI: 10.1002/adma.202100472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Wagner V, Gil J. Senescence as a therapeutically relevant response to CDK4/6 inhibitors. Oncogene 2020;39:5165-76. [PMID: 32541838 DOI: 10.1038/s41388-020-1354-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
15 De Conti G, Dias MH, Bernards R. Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells. Cancers (Basel) 2021;13:1118. [PMID: 33807785 DOI: 10.3390/cancers13051118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yin Y, Chen H, Wang Y, Zhang L, Wang X. Roles of extracellular vesicles in the aging microenvironment and age-related diseases. J Extracell Vesicles 2021;10:e12154. [PMID: 34609061 DOI: 10.1002/jev2.12154] [Reference Citation Analysis]
17 Feucht J, Abou-El-Enein M. Senolytic CAR T Cells in Solid Tumors and Age-Related Pathologies. Mol Ther 2020;28:2108-10. [PMID: 32841587 DOI: 10.1016/j.ymthe.2020.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Yu Z, Deng P, Chen Y, Liu S, Chen J, Yang Z, Chen J, Fan X, Wang P, Cai Z, Wang Y, Hu P, Lin D, Xiao R, Zou Y, Huang Y, Yu Q, Lan P, Tan J, Wu X. Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer. Adv Sci (Weinh) 2021;8:e2100759. [PMID: 34881526 DOI: 10.1002/advs.202100759] [Reference Citation Analysis]
19 Fitsiou E, Soto-Gamez A, Demaria M. Biological functions of therapy-induced senescence in cancer. Semin Cancer Biol 2021:S1044-579X(21)00071-7. [PMID: 33775830 DOI: 10.1016/j.semcancer.2021.03.021] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Taranto D, Ramirez CFA, Vegna S, de Groot MHP, de Wit N, Van Baalen M, Klarenbeek S, Akkari L. Multiparametric Analyses of Hepatocellular Carcinoma Somatic Mouse Models and Their Associated Tumor Microenvironment. Curr Protoc 2021;1:e147. [PMID: 34101385 DOI: 10.1002/cpz1.147] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Fang C, Li W, Yin R, Zhu D, Liu X, Wu H, Wang Q, Wang W, Bai Q, Chen B, Yao X, Chen Y. Potent antitumor activity of a glutamyltransferase-derived peptide via an activation of oncosis pathway. Sci Rep 2021;11:16507. [PMID: 34389740 DOI: 10.1038/s41598-021-93055-5] [Reference Citation Analysis]
22 Baú-Carneiro JL, Akemi Guirao Sumida I, Gallon M, Zaleski T, Boia-Ferreira M, Bridi Cavassin F. Sertraline repositioning: an overview of its potential use as a chemotherapeutic agent after four decades of tumor reversal studies. Transl Oncol 2021;16:101303. [PMID: 34911014 DOI: 10.1016/j.tranon.2021.101303] [Reference Citation Analysis]
23 Jin Y, Yang R, Ding J, Zhu F, Zhu C, Xu Q, Cai J. KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP. Biochem Biophys Res Commun 2021;585:185-90. [PMID: 34808502 DOI: 10.1016/j.bbrc.2021.09.009] [Reference Citation Analysis]
24 Boshuizen J, Peeper DS. Rational Cancer Treatment Combinations: An Urgent Clinical Need. Molecular Cell 2020;78:1002-18. [DOI: 10.1016/j.molcel.2020.05.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
25 Guo Y, Wang J, Benedict B, Yang C, van Gemert F, Ma X, Gao D, Wang H, Zhang S, Lieftink C, Beijersbergen RL, Te Riele H, Qiao X, Gao Q, Sun C, Qin W, Bernards R, Wang C. Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer. Genome Med 2021;13:166. [PMID: 34663432 DOI: 10.1186/s13073-021-00981-0] [Reference Citation Analysis]
26 Wang C, Cao Y, Yang C, Bernards R, Qin W. Exploring liver cancer biology through functional genetic screens. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34163045 DOI: 10.1038/s41575-021-00465-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Xu D, Yang H, Schmid RA, Peng RW. Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight. Front Oncol 2020;10:579464. [PMID: 33072611 DOI: 10.3389/fonc.2020.579464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Tan Q, Liang N, Zhang X, Li J. Dynamic Aging: Channeled Through Microenvironment. Front Physiol 2021;12:702276. [PMID: 34366891 DOI: 10.3389/fphys.2021.702276] [Reference Citation Analysis]
29 Yang H, Xuefeng Y, Shandong W, Jianhua X. COX-2 in liver fibrosis. Clin Chim Acta 2020;506:196-203. [PMID: 32184095 DOI: 10.1016/j.cca.2020.03.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Yang C, Huang X, Li Y, Chen J, Lv Y, Dai S. Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology. Brief Bioinform 2021;22:bbaa164. [PMID: 32789496 DOI: 10.1093/bib/bbaa164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
31 Varughese FM, Demaria M. A novel transcriptomic-based classifier for senescent cancer cells. Trends Cancer 2021;7:971-3. [PMID: 34548270 DOI: 10.1016/j.trecan.2021.09.001] [Reference Citation Analysis]
32 Prasanna PG, Citrin DE, Hildesheim J, Ahmed MM, Venkatachalam S, Riscuta G, Xi D, Zheng G, van Deursen J, Goronzy J, Kron SJ, Anscher MS, Sharpless NE, Campisi J, Brown SL, Niedernhofer LJ, O'Loghlen A, Georgakilas AG, Paris F, Gius D, Gewirtz DA, Schmitt CA, Abazeed ME, Kirkland JL, Richmond A, Romesser PB, Lowe SW, Gil J, Mendonca MS, Burma S, Zhou D, Coleman CN. Therapy-Induced Senescence: Opportunities to Improve Anti-Cancer Therapy. J Natl Cancer Inst 2021:djab064. [PMID: 33792717 DOI: 10.1093/jnci/djab064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Yu B, Mamedov R, Fuhler GM, Peppelenbosch MP. Drug Discovery in Liver Disease Using Kinome Profiling. Int J Mol Sci 2021;22:2623. [PMID: 33807722 DOI: 10.3390/ijms22052623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Feng M, Pan Y, Kong R, Shu S. Therapy of Primary Liver Cancer. Innovation (N Y) 2020;1:100032. [PMID: 32914142 DOI: 10.1016/j.xinn.2020.100032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
35 Ma Y, Chai N, Jiang Q, Chang Z, Chai Y, Li X, Sun H, Hou J, Linghu E. DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents. Pharmacol Res 2020;160:105071. [PMID: 32659427 DOI: 10.1016/j.phrs.2020.105071] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
36 Müller M, Bird TG, Nault JC. The landscape of gene mutations in cirrhosis and hepatocellular carcinoma. J Hepatol 2020;72:990-1002. [PMID: 32044402 DOI: 10.1016/j.jhep.2020.01.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
37 Amor C, Feucht J, Leibold J, Ho Y, Zhu C, Alonso-curbelo D, Mansilla-soto J, Boyer JA, Li X, Giavridis T, Kulick A, Houlihan S, Peerschke E, Friedman SL, Ponomarev V, Piersigilli A, Sadelain M, Lowe SW. Senolytic CAR T cells reverse senescence-associated pathologies. Nature 2020;583:127-32. [DOI: 10.1038/s41586-020-2403-9] [Cited by in Crossref: 118] [Cited by in F6Publishing: 120] [Article Influence: 59.0] [Reference Citation Analysis]
38 Zhang DY, Monteiro MJ, Liu JP, Gu WY. Mechanisms of cancer stem cell senescence: Current understanding and future perspectives. Clin Exp Pharmacol Physiol 2021;48:1185-202. [PMID: 34046925 DOI: 10.1111/1440-1681.13528] [Reference Citation Analysis]
39 Liu L, Liu Z, Meng L, Li L, Gao J, Yu S, Hu B, Yang H, Guo W, Zhang S. An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma. Front Mol Biosci 2021;8:766609. [PMID: 34970594 DOI: 10.3389/fmolb.2021.766609] [Reference Citation Analysis]
40 Yu Y, Wang Z, Huang Z, Tang X, Huang X, Li W. C1orf61 promotes hepatocellular carcinoma metastasis and increases the therapeutic response to sorafenib. Biochim Biophys Acta Mol Cell Res 2021;1868:119048. [PMID: 33915231 DOI: 10.1016/j.bbamcr.2021.119048] [Reference Citation Analysis]
41 Wolter K, Zender L. Therapy-induced senescence - an induced synthetic lethality in liver cancer? Nat Rev Gastroenterol Hepatol 2020;17:135-6. [PMID: 31965074 DOI: 10.1038/s41575-020-0262-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Saleh T, Carpenter VJ, Bloukh S, Gewirtz DA. Targeting tumor cell senescence and polyploidy as potential therapeutic strategies. Semin Cancer Biol 2020:S1044-579X(20)30270-4. [PMID: 33358748 DOI: 10.1016/j.semcancer.2020.12.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
43 Wu X, Ma W, Mei C, Chen X, Yao Y, Liu Y, Qin X, Yuan Y. Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment. J Exp Clin Cancer Res. 2020;39:97. [PMID: 32487115 DOI: 10.1186/s13046-020-01603-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Zhou L, Jilderda LJ, Foijer F. Exploiting aneuploidy-imposed stresses and coping mechanisms to battle cancer. Open Biol 2020;10:200148. [PMID: 32873156 DOI: 10.1098/rsob.200148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Hou D, Xiong J, Li Y, Peng Y, Xiong L. Efficacy and safety of Xiaoaiping injection for liver cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21993. [PMID: 32871951 DOI: 10.1097/MD.0000000000021993] [Reference Citation Analysis]
46 Zhen Z, Zhu S, Jin J, Wang L, Lu W. A water-soluble probe with p-hydroxybenzyl quaternary ammonium linker for selective imaging in senescent cells. Anal Chim Acta 2020;1133:99-108. [PMID: 32993878 DOI: 10.1016/j.aca.2020.07.079] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Schmidt-Arras D, Galun E, Rose-John S. The two facets of gp130 signalling in liver tumorigenesis. Semin Immunopathol 2021. [PMID: 34047814 DOI: 10.1007/s00281-021-00861-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Francies HE, Mcdermott U, Garnett MJ. Genomics-guided pre-clinical development of cancer therapies. Nat Cancer 2020;1:482-92. [DOI: 10.1038/s43018-020-0067-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
49 Cinnamon E, Pikarsky E. Are we ready for targeted therapy combinations in HCC? Gut 2020;69:613-4. [PMID: 31915236 DOI: 10.1136/gutjnl-2019-319780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Hong Z, Lu Y, Ran C, Tang P, Huang J, Yang Y, Duan X, Wu H. The bioactive ingredients in Actinidia chinensis Planch. Inhibit liver cancer by inducing apoptosis. J Ethnopharmacol 2021;281:114553. [PMID: 34428524 DOI: 10.1016/j.jep.2021.114553] [Reference Citation Analysis]
51 Liu H, Zhao H, Sun Y. Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies. Semin Cancer Biol 2021:S1044-579X(21)00271-6. [PMID: 34799201 DOI: 10.1016/j.semcancer.2021.11.004] [Reference Citation Analysis]
52 Ferreira-Gonzalez S, Rodrigo-Torres D, Gadd VL, Forbes SJ. Cellular Senescence in Liver Disease and Regeneration. Semin Liver Dis 2021;41:50-66. [PMID: 33764485 DOI: 10.1055/s-0040-1722262] [Reference Citation Analysis]
53 Gallage S, García-beccaria M, Szydlowska M, Rahbari M, Mohr R, Tacke F, Heikenwalder M. The therapeutic landscape of hepatocellular carcinoma. Med 2021;2:505-52. [DOI: 10.1016/j.medj.2021.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Chen Y, Li L, Lan J, Cui Y, Rao X, Zhao J, Xing T, Ju G, Song G, Lou J, Liang J. CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma. Mol Cancer 2022;21:11. [PMID: 34983546 DOI: 10.1186/s12943-021-01466-9] [Reference Citation Analysis]
55 Borghesan M, Hoogaars WMH, Varela-Eirin M, Talma N, Demaria M. A Senescence-Centric View of Aging: Implications for Longevity and Disease. Trends Cell Biol 2020;30:777-91. [PMID: 32800659 DOI: 10.1016/j.tcb.2020.07.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]
56 Davan-Wetton CSA, Pessolano E, Perretti M, Montero-Melendez T. Senescence under appraisal: hopes and challenges revisited. Cell Mol Life Sci 2021;78:3333-54. [PMID: 33439271 DOI: 10.1007/s00018-020-03746-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
57 Li F, Huangyang P, Burrows M, Guo K, Riscal R, Godfrey J, Lee KE, Lin N, Lee P, Blair IA, Keith B, Li B, Simon MC. FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome. Nat Cell Biol 2020;22:728-39. [PMID: 32367049 DOI: 10.1038/s41556-020-0511-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
58 Liu Y, Xue M, Cao D, Qin L, Wang Y, Miao Z, Wang P, Hu X, Shen J, Xiong B. Multi-omics characterization of WNT pathway reactivation to ameliorate BET inhibitor resistance in liver cancer cells. Genomics 2021;113:1057-69. [PMID: 33667649 DOI: 10.1016/j.ygeno.2021.02.017] [Reference Citation Analysis]
59 Tang L, Chen R, Xu X. Synthetic lethality: A promising therapeutic strategy for hepatocellular carcinoma. Cancer Lett 2020;476:120-8. [PMID: 32070778 DOI: 10.1016/j.canlet.2020.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Gonzalez-Meljem JM, Martinez-Barbera JP. Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis. Cell Mol Life Sci 2021;78:4521-44. [PMID: 34019103 DOI: 10.1007/s00018-021-03798-7] [Reference Citation Analysis]
61 Görgülü K, Lesina M, Algül H. Combating pancreatic cancer during its Rip Van Winkle sleep. Cell Res 2020;30:637-8. [PMID: 32494021 DOI: 10.1038/s41422-020-0348-z] [Reference Citation Analysis]
62 Hong X, Luo H, Zhu G, Guan X, Jia Y, Yu H, Lv X, Yu T, Lan H, Zhang Q, Li H, Sun W, Huang X, Li J. SSR2 overexpression associates with tumorigenesis and metastasis of Hepatocellular Carcinoma through modulating EMT. J Cancer 2020;11:5578-87. [PMID: 32913453 DOI: 10.7150/jca.44788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Mittermeier C, Konopa A, Muehlich S. Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma. Cells 2020;9:E2540. [PMID: 33255630 DOI: 10.3390/cells9122540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
64 Dolson A, Sauty SM, Shaban K, Yankulov K. Dbf4-Dependent Kinase: DDK-ated to post-initiation events in DNA replication. Cell Cycle 2021;20:2348-60. [PMID: 34662256 DOI: 10.1080/15384101.2021.1986999] [Reference Citation Analysis]
65 Okamura K, Suzuki T, Nohara K. Gestational arsenite exposure augments hepatic tumors of C3H mice by promoting senescence in F1 and F2 offspring via different pathways. Toxicol Appl Pharmacol 2020;408:115259. [PMID: 33010264 DOI: 10.1016/j.taap.2020.115259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Qing Y, Li H, Zhao Y, Hu P, Wang X, Yu X, Zhu M, Wang H, Wang Z, Guo Q, Hui H. One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence. Oxid Med Cell Longev 2021;2021:5529518. [PMID: 34603598 DOI: 10.1155/2021/5529518] [Reference Citation Analysis]
67 Liao C, Xiao Y, Liu L. The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence. Cancer Manag Res 2020;12:13553-66. [PMID: 33408525 DOI: 10.2147/CMAR.S285083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
68 Song L, Luo Y, Li S, Hong M, Wang Q, Chi X, Yang C. ISL Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via Downregulation of PI3K/AKT/mTOR Pathway in vivo and in vitro. Drug Des Devel Ther 2020;14:4363-76. [PMID: 33116421 DOI: 10.2147/DDDT.S270124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Giannakoulis VG, Dubovan P, Papoutsi E, Kataki A, Koskinas J. Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective. Cancers (Basel) 2021;13:4732. [PMID: 34572959 DOI: 10.3390/cancers13184732] [Reference Citation Analysis]
70 Shi D, Hu L, Li X, Liu W, Gao Y, Li X, Jiang B, Xia C, Guo Y, Li J. Lysosomal polarity increases with aging as revealed by a lysosome-targetable near-infrared fluorescent probe. Sensors and Actuators B: Chemical 2020;319:128302. [DOI: 10.1016/j.snb.2020.128302] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
71 Golonka RM, Vijay-Kumar M. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome. Adv Cancer Res 2021;149:171-255. [PMID: 33579424 DOI: 10.1016/bs.acr.2020.10.004] [Reference Citation Analysis]
72 Carpenter VJ, Saleh T, Gewirtz DA. Senolytics for Cancer Therapy: Is All That Glitters Really Gold? Cancers (Basel) 2021;13:723. [PMID: 33578753 DOI: 10.3390/cancers13040723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
73 Malaquin N, Vancayseele A, Gilbert S, Antenor-Habazac L, Olivier MA, Ait Ali Brahem Z, Saad F, Delouya G, Rodier F. DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity. Cells 2020;9:E1593. [PMID: 32630281 DOI: 10.3390/cells9071593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
74 Dang F, Nie L, Zhou J, Shimizu K, Chu C, Wu Z, Fassl A, Ke S, Wang Y, Zhang J, Zhang T, Tu Z, Inuzuka H, Sicinski P, Bass AJ, Wei W. Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer. Nat Commun 2021;12:5386. [PMID: 34508104 DOI: 10.1038/s41467-021-25700-6] [Reference Citation Analysis]
75 Wang Z, Gao J, Liu H, Ohno Y, Xu C. Targeting senescent cells and tumor therapy (Review). Int J Mol Med 2020;46:1603-10. [PMID: 33000195 DOI: 10.3892/ijmm.2020.4705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
76 Sauer S, Reed DR, Ihnat M, Hurst RE, Warshawsky D, Barkan D. Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells. Front Oncol 2021;11:659963. [PMID: 33987095 DOI: 10.3389/fonc.2021.659963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Karabicici M, Alptekin S, Fırtına Karagonlar Z, Erdal E. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7. Mol Oncol 2021;15:2185-202. [PMID: 33524223 DOI: 10.1002/1878-0261.12916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
78 Jochems F, Thijssen B, De Conti G, Jansen R, Pogacar Z, Groot K, Wang L, Schepers A, Wang C, Jin H, Beijersbergen RL, Leite de Oliveira R, Wessels LFA, Bernards R. The Cancer SENESCopedia: A delineation of cancer cell senescence. Cell Rep 2021;36:109441. [PMID: 34320349 DOI: 10.1016/j.celrep.2021.109441] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Saavedra-García P, Roman-Trufero M, Al-Sadah HA, Blighe K, López-Jiménez E, Christoforou M, Penfold L, Capece D, Xiong X, Miao Y, Parzych K, Caputo VS, Siskos AP, Encheva V, Liu Z, Thiel D, Kaiser MF, Piazza P, Chaidos A, Karadimitris A, Franzoso G, Snijders AP, Keun HC, Oyarzún DA, Barahona M, Auner HW. Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs. Proc Natl Acad Sci U S A 2021;118:e2018229118. [PMID: 33883278 DOI: 10.1073/pnas.2018229118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Triana-Martínez F, Loza MI, Domínguez E. Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy. Cells 2020;9:E346. [PMID: 32028565 DOI: 10.3390/cells9020346] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
81 He GN, Bao NR, Wang S, Xi M, Zhang TH, Chen FS. Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1/miR-214-3p/GPX4. Drug Des Devel Ther 2021;15:3965-78. [PMID: 34566408 DOI: 10.2147/DDDT.S332847] [Reference Citation Analysis]
82 Wang B, Kohli J, Demaria M. Senescent Cells in Cancer Therapy: Friends or Foes? Trends Cancer 2020;6:838-57. [PMID: 32482536 DOI: 10.1016/j.trecan.2020.05.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 28.5] [Reference Citation Analysis]
83 Deng F, Chen D, Wei X, Lu S, Luo X, He J, Liu J, Meng T, Yang A, Chen H. Development and validation of a prognostic classifier based on HIF-1 signaling for hepatocellular carcinoma. Aging (Albany NY) 2020;12:3431-50. [PMID: 32084009 DOI: 10.18632/aging.102820] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
84 Yuan L, Alexander PB, Wang XF. Cellular senescence: from anti-cancer weapon to anti-aging target. Sci China Life Sci 2020;63:332-42. [PMID: 32060861 DOI: 10.1007/s11427-019-1629-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
85 Chambers CR, Ritchie S, Pereira BA, Timpson P. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer. Mol Oncol 2021. [PMID: 34137158 DOI: 10.1002/1878-0261.13042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
86 Liu P, Tang Q, Chen M, Chen W, Lu Y, Liu Z, He Z. Hepatocellular Senescence: Immunosurveillance and Future Senescence-Induced Therapy in Hepatocellular Carcinoma. Front Oncol 2020;10:589908. [PMID: 33330071 DOI: 10.3389/fonc.2020.589908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
87 El Tekle G, Bernasocchi T, Unni AM, Bertoni F, Rossi D, Rubin MA, Theurillat JP. Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us. Trends Cancer 2021;7:823-36. [PMID: 34031014 DOI: 10.1016/j.trecan.2021.04.009] [Reference Citation Analysis]
88 Lv X, Yu H, Zhang Q, Huang Q, Hong X, Yu T, Lan H, Mei C, Zhang W, Luo H, Pang P, Shan H. SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling. J Cell Mol Med 2020;24:10714-29. [PMID: 32746503 DOI: 10.1111/jcmm.15693] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
89 Zheng K, Ma J, Wang Y, He Z, Deng K. Sulforaphane Inhibits Autophagy and Induces Exosome-Mediated Paracrine Senescence via Regulating mTOR/TFE3. Mol Nutr Food Res 2020;64:e1901231. [PMID: 32476238 DOI: 10.1002/mnfr.201901231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
90 Hu F, Zhang R, Guo W, Yan T, He X, Hu F, Ren F, Ma X, Lei J, Zheng W. PEGylated-PLGA Nanoparticles Coated with pH-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer. Mol Pharm 2021;18:2161-73. [PMID: 32515968 DOI: 10.1021/acs.molpharmaceut.0c00321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
91 Yang C, Guo Y, Qian R, Huang Y, Zhang L, Wang J, Huang X, Liu Z, Qin W, Wang C, Chen H, Ma X, Zhang D. Mapping the landscape of synthetic lethal interactions in liver cancer. Theranostics 2021;11:9038-53. [PMID: 34522226 DOI: 10.7150/thno.63416] [Reference Citation Analysis]
92 Li X, Qiu W, Li J, Chen X, Hu Y, Gao Y, Shi D, Li X, Lin H, Hu Z, Dong G, Sheng C, Jiang B, Xia C, Kim CY, Guo Y, Li J. First-generation species-selective chemical probes for fluorescence imaging of human senescence-associated β-galactosidase. Chem Sci 2020;11:7292-301. [PMID: 34123013 DOI: 10.1039/d0sc01234c] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 7.5] [Reference Citation Analysis]
93 Xu X, Shen X, Feng W, Yang D, Jin L, Wang J, Wang M, Ting Z, Xue F, Zhang J, Meng C, Chen R, Zheng X, Du L, Xuan L, Wang Y, Xie T, Huang Z. D-galactose induces senescence of glioblastoma cells through YAP-CDK6 pathway. Aging (Albany NY) 2020;12:18501-21. [PMID: 32991321 DOI: 10.18632/aging.103819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
94 Liu D, Zhao X, Tang A, Xu X, Liu S, Zha L, Ma W, Zheng J, Shi M. CRISPR screen in mechanism and target discovery for cancer immunotherapy. Biochim Biophys Acta Rev Cancer 2020;1874:188378. [PMID: 32413572 DOI: 10.1016/j.bbcan.2020.188378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
95 Saleh T, Carpenter VJ, Tyutyunyk-Massey L, Murray G, Leverson JD, Souers AJ, Alotaibi MR, Faber AC, Reed J, Harada H, Gewirtz DA. Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-XL -BAX interaction. Mol Oncol 2020;14:2504-19. [PMID: 32652830 DOI: 10.1002/1878-0261.12761] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
96 Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol 2021. [PMID: 34508254 DOI: 10.1038/s41580-021-00404-3] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
97 Zhang JW, Zhang D, Yu BP. Senescent cells in cancer therapy: why and how to remove them. Cancer Lett 2021;520:68-79. [PMID: 34237406 DOI: 10.1016/j.canlet.2021.07.002] [Reference Citation Analysis]
98 Luo D, Hou D, Wen T, Feng M, Zhang H. Efficacy and safety of Brucea javanica oil emulsion for liver cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e23197. [PMID: 33217831 DOI: 10.1097/MD.0000000000023197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]